⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of PharmCube and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
PharmCube
↗Shanghai, China
PharmCube is a prominent healthcare data, media, and consulting company specializing in the Chinese and global pharmaceutical industries. The company provides critical intelligence, market insights, and strategic planning support to pharmaceutical companies and investment institutions through a comprehensive suite of data products and services.
By integrating "data + AI" with industry expertise, PharmCube offers a product matrix that covers the entire life cycle of drugs and medical devices. Their offerings include global new drug databases (NextBiopharm), clinical trial tracking (TrialiCube), investment and financing intelligence (MedAlpha), and market sales analysis (PharmaBI), helping clients navigate complex regulatory landscapes and market shifts.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Pharmaceutical Data & Intelligence
SIZE & FINANCIALS
Employees:51-200
Founded:2015
Ownership:private
Status:operating
FUNDING
Stage:Private Equity-Backed
PIPELINE
Modalities:Small molecule, mAb, ADC, Cell therapy, Gene therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Endpoints News (Content partnership for China biopharma coverage)
COMPETITION
Position:Leader
Competitors:Clarivate, IQVIA, GlobalData, EvaluatePharma
LEADERSHIP
Key Executives:
Guo Chaowei - Contact/Representative
LINKS
Website:pharmcube.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PharmCube. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.